Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd
Firmenname:
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd
Telefon:
0755-22677922
E-Mail:
2851922760@qq.com
Nationalität:
China
URL:
www.hdimpurity.com/egoods&serv=16
Produkte insgesamt:
5043
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Produktkatalog
Remimazolam Impurity 1
Methylcrotonat
623-43-8
C5H8O2
Remimazolam Impurity 8
1,2-Epoxypropan
75-56-9
C3H6O
Remimazolam Impurity 6
1,1'-Iminodipropan-2-ol
110-97-4
C6H15NO2
Empagliflozin Impurity 65
4-Methylmorpholin
109-02-4
C5H11NO
Apixaban Impurity 54
4-Ethoxyanilin
156-43-4
C8H11NO
Apixaban Impurity 53
4-Chloranilin
106-47-8
C6H6ClN
Empagliflozin Impurity 66
Chlortrimethylsilan
75-77-4
C3H9ClSi
Remdesivir impurity
1355149-45-9
C12H16N5O13P3
Pitavastatin Impurity 7
147489-06-3
C32H36FNO4
Pitavastatin Impurity 5
Pitavastatin Impurity 13
Pramipexole Impurity V
Pramipexole Impurity Z
Pitavastatin Impurity 23
Favipiravir Impurity
Pitavastatin Impurity 22
Sofosbuvir Impurity A
1496552-16-9
C22H29FN3O9P
Pitavastatin Impurity 23
1467166-39-7
C28H28FNO4
Pitavastatin Impurity 11
Pitavastatin Impurity 20
Parecoxib Impurity 26
75115-00-3
C16H13NO
Parecoxib Impurity 25
198470-85-8
C19H19N2NaO4S
Tofacitinib Impurity 3
1206825-36-6
C13H19N5
Parecoxib sodium Impurity 31
477594-28-8
C19H18N2O4S
Parecoxib sodium Impurity 31
501093-49-8
C16H14N2O4S
Tofacitinib Impurity 2
477600-73-0
C20H25N5
sofosbuvir impurity 3
1496551-70-2
C31H26ClN3O7
Parecoxib sodium Impurity 31
198470-91-6
C20H20N2O4S
Parecoxib Impurity 20
181696-12-8
C16H14N2O3S
Parecoxib Impurity 9
1373038-60-8
C32H25N3O6S2
Parecoxib Impurity 24
198470-83-6
C20H21N2NaO4S
Parecoxib Impurity 21
181696-73-1
C16H15NO2
Pitavastatin Impurity 8
849811-78-5
C26H26FNO4
Pitavastatin Impurity 16
1187966-93-3
C25H22FNO4
Pitavastatin Impurity 17
586966-54-3
C29H32FNO4
Pitavastatin Impurity 18
254452-88-5
C25H26CaFNO4
Clavulanic acid Impurity A
4744-51-8
C8H12N2O2
Clavulanic acid Impurity B
96681-85-5
C11H16N2O4
Pitavastatin Impurity 19
769908-13-6
C25H24FNO4
Potassium clavulanate
Kalium-[2R-(2α,3Z,5α)]-3-(2-hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-2-carboxylat
61177-45-5
C8H10KNO5
Pitavastatin Impurity 21
254452-92-1
C25H26CaFNO4
Tofacitinib Impurity 5
1062580-52-2
C14H23ClN2
Parecoxib Impurity 12
2229657-81-0
C19H18N2O4S
Parecoxib Impurity 11
1709956-89-7
C19H18N2O4S
Tofacitinib Impurity 6
3680-69-1
C6H4ClN3
Parecoxib Impurity 10
198471-06-6
C18H16N2O4S
Parecoxib sodium Impurity 31
2338845-31-9
C32H24N2O4S
Parecoxib Impurity T
198471-83-9
C19H18N2O5S
Parecoxib Impurity 23
198470-82-5
C20H20N2O4S
Tofacitinib Impurity 4
923036-30-0
C27H31N5O2S
Parecoxib Impurity 15
473465-11-1
C18H18N2O3S
Tofacitinib Impurity C
1092578-47-6
C16H20N6O
Tofacitinib Impurity E
1616760-97-4
C13H18ClN5
Tofacitinib Impurity 7
90213-66-4
C6H3Cl2N3
Tofacitinib Impurity 1
479633-63-1
C13H10ClN3O2S
Parecoxib Impurity 2
509074-26-4
C16H12ClNO3S
Apixaban Impurity S2
1643330-62-4
C20H26ClN3O3
Ambroxol Impurity 6
2088879-81-4
C14H16Br2N2O
Parecoxib Impurity 4
181695-72-7
C16H14N2O3S
Apixaban Impurity 71
99585-01-0
C6H10Cl2O
Apixaban Impurity 11
503615-07-4
C22H22N4O4
Ambroxol Impurity 7
101900-44-1
C13H20BrClN2O
Parecoxib Impurity 5
386273-25-2
C16H14N2O3S
Apixaban Impurity 13
27143-07-3
C11H13ClN2O3
Ambroxol Impurity 10
609-85-8
C7H5Br2NO2
Apixaban Impurity 36
1801881-17-3
C24H23N5O3
Apixaban Impurity 49
503615-03-0
C15H17N3O4
Apixaban Impurity 15
1686149-78-9
C21H27N3O3
Apixaban Impurity 30
503612-47-3
C25H25N5O4
Ambroxol EP Impurity C
50910-53-7
C13H16Br2N2O
Parecoxib Impurity 1
37928-17-9
C16H13NO
Ambroxol EP Impurity B
18683-95-9
C14H18Br2N2O
Apixaban Impurity 41
503614-92-4
C25H24N4O5
Ambroxol EP Impurity D
1384955-66-1
C13H19Br2ClN2O
Ambroxol Impurity 11
105735-86-2
C13H16Br2N2O2
Parecoxib Impurity 6
1373038-56-2
C16H14N2O3S
Apixaban Impurity BMS-778960-01
2098457-92-0
C26H27N5O4
Apixaban Impurity BMS-724914-01
2187409-01-2
C25H28N6O4
Apixaban Impurity 12
1423803-24-0
C20H19N5O3
Ambroxol hydrochloride
Ambroxol
18683-91-5
C13H18Br2N2O
Pitavastatin Impurity 9
167073-19-0
C27H28FNO4
Remimazolam Impurity 5
20776-51-6
C7H6BrNO2
Remimazolam Impurity 2
Methyl-4-bromcrotonat
1117-71-1
C5H7BrO2
Remimazolam Impurity 7
1,1',1''-Nitrilotripropan-2-ol
122-20-3
C9H21NO3
Remimazolam Impurity 4
13991-36-1
C4H5BrO2
Olopatadine Impurity 5
173174-07-7
C21H23NO4
Parecoxib Impurity 27
1373038-63-1
C16H11Cl2NO5S2
Tofacitinib Impurity A
1092578-46-5
C16H20N6O
Tofacitinib Impurity D
1252883-90-1
C20H25N5
Parecoxib Impurity 13
1708094-99-8
C22H23N3O7S2
Empagliflozin Impurity 69
7660-25-5
C6H12O6
Empagliflozin Impurity 70
D-Gluconsure
526-95-4
C6H12O7
Empagliflozin Impurity 76
219823-47-9
C11H14O4S
Empagliflozin Impurity 68
Glucose
50-99-7
C6H12O6
Pitavastatin Impurity 38
154170-27-1
C32H36FNO4
Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate
148901-69-3
C27H26FNO4
Empagliflozin Impurity 64
Hydroxytrimethylsilan
1066-40-6
C3H10OSi
Empagliflozin Impurity 67
N,N-Dimethylpyridin-4-amin
1122-58-3
C7H10N2
Pitavastatin Impurity 2
Pitavastatin Impurity 1
Pitavastatin Impurity 10
141750-63-2
C25H22FNO3
Pitavastatin Impurity 4
1980814-87-6
C25H24FNO5
Benazepril Enantiomer HCl
131064-75-0
C24H28N2O5
Pitavastatin Impurity 12
1159588-21-2
C25H26CaFNO4
Epalrestat
82159-09-9
C15H13NO3S2
Apixaban Impurity C
503614-91-3
C27H28N4O5
Tofacitinib Impurity FD+DX
1092578-48-7
C16H20N6O
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Copyright 2019 © ChemicalBook. All rights reserved